Advertisement

Index by Author

March 2000; 49 (3)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Abaterusso, C

    • Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate. Diabetes March 2000 49:476-484; doi:10.2337/diabetes.49.3.476

  2. Amiel, S A

    • Renal glucose production compensates for the liver during the anhepatic phase of liver transplantation. Diabetes March 2000 49:450-456; doi:10.2337/diabetes.49.3.450

  3. Argiolas, A

    • A PC-1 amino acid variant (K121Q) is associated with faster progression of renal disease in patients with type 1 diabetes and albuminuria. Diabetes March 2000 49:521-524; doi:10.2337/diabetes.49.3.521

B

  1. Baba, T

    • Association of the nitric oxide synthase gene polymorphism with an increased risk for progression to diabetic nephropathy in type 2 diabetes. Diabetes March 2000 49:500-503; doi:10.2337/diabetes.49.3.500

  2. Bacci, S

    • A PC-1 amino acid variant (K121Q) is associated with faster progression of renal disease in patients with type 1 diabetes and albuminuria. Diabetes March 2000 49:521-524; doi:10.2337/diabetes.49.3.521

  3. Bach, J F

    • Genetic and physical mapping of a type 1 diabetes susceptibility gene (IDDM12) to a 100-kb phagemid artificial chromosome clone containing D2S72-CTLA4-D2S105 on chromosome 2q33. Diabetes March 2000 49:492-499; doi:10.2337/diabetes.49.3.492

  4. Badenhoop, K

    • Vitamin D receptor allele combinations influence genetic susceptibility to type 1 diabetes in Germans. Diabetes March 2000 49:504-507; doi:10.2337/diabetes.49.3.504

  5. Baggio, B

    • Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate. Diabetes March 2000 49:476-484; doi:10.2337/diabetes.49.3.476

  6. Bariéty, J

    • Early glomerular macrophage recruitment in streptozotocin-induced diabetic rats. Diabetes March 2000 49:466-475; doi:10.2337/diabetes.49.3.466

  7. Barzon, I

    • Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate. Diabetes March 2000 49:476-484; doi:10.2337/diabetes.49.3.476

  8. Baur, M P

    • Vitamin D receptor allele combinations influence genetic susceptibility to type 1 diabetes in Germans. Diabetes March 2000 49:504-507; doi:10.2337/diabetes.49.3.504

  9. Bélair, M F

    • Early glomerular macrophage recruitment in streptozotocin-induced diabetic rats. Diabetes March 2000 49:466-475; doi:10.2337/diabetes.49.3.466

  10. Bennett, P H

    • Type 2 diabetes and low birth weight: the role of paternal inheritance in the association of low birth weight and diabetes. Diabetes March 2000 49:445-449; doi:10.2337/diabetes.49.3.445

  11. Berggren, P O

    • Synaptotagmin III isoform is compartmentalized in pancreatic beta-cells and has a functional role in exocytosis. Diabetes March 2000 49:383-391; doi:10.2337/diabetes.49.3.383

  12. Bergman, R N

    • Accurate measurement of endogenous insulin secretion does not require separate assessment of C-peptide kinetics. Diabetes March 2000 49:373-382; doi:10.2337/diabetes.49.3.373
    • Prolonged elevation of plasma free fatty acids impairs pancreatic beta-cell function in obese nondiabetic humans but not in individuals with type 2 diabetes. Diabetes March 2000 49:399-408; doi:10.2337/diabetes.49.3.399

  13. Biden, T J

    • Quantitative and functional characterization of muscarinic receptor subtypes in insulin-secreting cell lines and rat pancreatic islets. Diabetes March 2000 49:392-398; doi:10.2337/diabetes.49.3.392

  14. Blangero, J

    • Linkage of serum insulin concentrations to chromosome 3p in Mexican Americans. Diabetes March 2000 49:513-516; doi:10.2337/diabetes.49.3.513

  15. Bortoloso, E

    • Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate. Diabetes March 2000 49:476-484; doi:10.2337/diabetes.49.3.476

  16. Bouter, L M

    • Increased levels of soluble vascular cell adhesion molecule 1 are associated with risk of cardiovascular mortality in type 2 diabetes: the Hoorn study. Diabetes March 2000 49:485-491; doi:10.2337/diabetes.49.3.485

  17. Braun, J

    • Vitamin D receptor allele combinations influence genetic susceptibility to type 1 diabetes in Germans. Diabetes March 2000 49:504-507; doi:10.2337/diabetes.49.3.504

  18. Brocco, E

    • Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate. Diabetes March 2000 49:476-484; doi:10.2337/diabetes.49.3.476

  19. Broch, M

    • Interleukin-6 gene polymorphism and insulin sensitivity. Diabetes March 2000 49:517-520; doi:10.2337/diabetes.49.3.517

  20. Brown, H

    • Synaptotagmin III isoform is compartmentalized in pancreatic beta-cells and has a functional role in exocytosis. Diabetes March 2000 49:383-391; doi:10.2337/diabetes.49.3.383

  21. Bruneval, P

    • Early glomerular macrophage recruitment in streptozotocin-induced diabetic rats. Diabetes March 2000 49:466-475; doi:10.2337/diabetes.49.3.466

  22. Bruseghin, M

    • Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate. Diabetes March 2000 49:476-484; doi:10.2337/diabetes.49.3.476

  23. Buchan, A M

    • The extracellular calcium-sensing receptor on human beta-cells negatively modulates insulin secretion. Diabetes March 2000 49:409-417; doi:10.2337/diabetes.49.3.409

C

  1. Carpenter, L

    • Quantitative and functional characterization of muscarinic receptor subtypes in insulin-secreting cell lines and rat pancreatic islets. Diabetes March 2000 49:392-398; doi:10.2337/diabetes.49.3.392

  2. Carpentier, A

    • Prolonged elevation of plasma free fatty acids impairs pancreatic beta-cell function in obese nondiabetic humans but not in individuals with type 2 diabetes. Diabetes March 2000 49:399-408; doi:10.2337/diabetes.49.3.399

  3. Carraro, A

    • Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate. Diabetes March 2000 49:476-484; doi:10.2337/diabetes.49.3.476

  4. Carruba, M O

    • Induction of fatty acid translocase/CD36, peroxisome proliferator-activated receptor-gamma2, leptin, uncoupling proteins 2 and 3, and tumor necrosis factor-alpha gene expression in human subcutaneous fat by lipid infusion. Diabetes March 2000 49:319-324; doi:10.2337/diabetes.49.3.319

  5. Casamitjana, R

    • Interleukin-6 gene polymorphism and insulin sensitivity. Diabetes March 2000 49:517-520; doi:10.2337/diabetes.49.3.517

  6. Chen, G

    • Isolation of INS-1-derived cell lines with robust ATP-sensitive K+ channel-dependent and -independent glucose-stimulated insulin secretion. Diabetes March 2000 49:424-430; doi:10.2337/diabetes.49.3.424

  7. Chiesura-Corona, M

    • Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate. Diabetes March 2000 49:476-484; doi:10.2337/diabetes.49.3.476

  8. Christie, M R

    • T-cell lines reactive to an immunodominant epitope of the tyrosine phosphatase-like autoantigen IA-2 in type 1 diabetes. Diabetes March 2000 49:356-366; doi:10.2337/diabetes.49.3.356

  9. Cole, S A

    • Linkage of serum insulin concentrations to chromosome 3p in Mexican Americans. Diabetes March 2000 49:513-516; doi:10.2337/diabetes.49.3.513

  10. Comuzzie, A G

    • Linkage of serum insulin concentrations to chromosome 3p in Mexican Americans. Diabetes March 2000 49:513-516; doi:10.2337/diabetes.49.3.513

  11. Corbett, J A

    • Anti-inflammatory actions of 15-deoxy-delta 12,14-prostaglandin J2 and troglitazone: evidence for heat shock-dependent and -independent inhibition of cytokine-induced inducible nitric oxide synthase expression. Diabetes March 2000 49:346-355; doi:10.2337/diabetes.49.3.346

  12. Corkey, B E

    • Synaptotagmin III isoform is compartmentalized in pancreatic beta-cells and has a functional role in exocytosis. Diabetes March 2000 49:383-391; doi:10.2337/diabetes.49.3.383

  13. Cosgrove, K E

    • Glucose modulation of insulin mRNA levels is dependent on transcription factor PDX-1 and occurs independently of changes in intracellular Ca2+. Diabetes March 2000 49:418-423; doi:10.2337/diabetes.49.3.418

  14. Crossey, P A

    • Dysregulation of the insulin/IGF binding protein-1 axis in transgenic mice is associated with hyperinsulinemia and glucose intolerance. Diabetes March 2000 49:457-465; doi:10.2337/diabetes.49.3.457

  15. Curtis, S B

    • The extracellular calcium-sensing receptor on human beta-cells negatively modulates insulin secretion. Diabetes March 2000 49:409-417; doi:10.2337/diabetes.49.3.409

D

  1. Dabelea, D

    • Type 2 diabetes and low birth weight: the role of paternal inheritance in the association of low birth weight and diabetes. Diabetes March 2000 49:445-449; doi:10.2337/diabetes.49.3.445

  2. Dalla Vestra, M

    • Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate. Diabetes March 2000 49:476-484; doi:10.2337/diabetes.49.3.476

  3. De Cosmo, S

    • A PC-1 amino acid variant (K121Q) is associated with faster progression of renal disease in patients with type 1 diabetes and albuminuria. Diabetes March 2000 49:521-524; doi:10.2337/diabetes.49.3.521

  4. Deeney, J

    • Synaptotagmin III isoform is compartmentalized in pancreatic beta-cells and has a functional role in exocytosis. Diabetes March 2000 49:383-391; doi:10.2337/diabetes.49.3.383

  5. Dekker, J M

    • Increased levels of soluble vascular cell adhesion molecule 1 are associated with risk of cardiovascular mortality in type 2 diabetes: the Hoorn study. Diabetes March 2000 49:485-491; doi:10.2337/diabetes.49.3.485

  6. Docherty, K

    • Glucose modulation of insulin mRNA levels is dependent on transcription factor PDX-1 and occurs independently of changes in intracellular Ca2+. Diabetes March 2000 49:418-423; doi:10.2337/diabetes.49.3.418

  7. Donner, H

    • Vitamin D receptor allele combinations influence genetic susceptibility to type 1 diabetes in Germans. Diabetes March 2000 49:504-507; doi:10.2337/diabetes.49.3.504

  8. Drijfhout, J W

    • T-cell lines reactive to an immunodominant epitope of the tyrosine phosphatase-like autoantigen IA-2 in type 1 diabetes. Diabetes March 2000 49:356-366; doi:10.2337/diabetes.49.3.356

  9. Dunne, M J

    • Glucose modulation of insulin mRNA levels is dependent on transcription factor PDX-1 and occurs independently of changes in intracellular Ca2+. Diabetes March 2000 49:418-423; doi:10.2337/diabetes.49.3.418

E

  1. Eckenrode, S E

    • Genetic and physical mapping of a type 1 diabetes susceptibility gene (IDDM12) to a 100-kb phagemid artificial chromosome clone containing D2S72-CTLA4-D2S105 on chromosome 2q33. Diabetes March 2000 49:492-499; doi:10.2337/diabetes.49.3.492

  2. Eizirik, D L

    • Interleukin-1beta-induced alteration in a beta-cell phenotype can reduce cellular sensitivity to conditions that cause necrosis but not to cytokine-induced apoptosis. Diabetes March 2000 49:340-345; doi:10.2337/diabetes.49.3.340

  3. Emeis, J J

    • Increased levels of soluble vascular cell adhesion molecule 1 are associated with risk of cardiovascular mortality in type 2 diabetes: the Hoorn study. Diabetes March 2000 49:485-491; doi:10.2337/diabetes.49.3.485

F

  1. Federspil, G

    • Induction of fatty acid translocase/CD36, peroxisome proliferator-activated receptor-gamma2, leptin, uncoupling proteins 2 and 3, and tumor necrosis factor-alpha gene expression in human subcutaneous fat by lipid infusion. Diabetes March 2000 49:319-324; doi:10.2337/diabetes.49.3.319

  2. Fernández-Real, J M

    • Interleukin-6 gene polymorphism and insulin sensitivity. Diabetes March 2000 49:517-520; doi:10.2337/diabetes.49.3.517

  3. Fioretto, P

    • Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate. Diabetes March 2000 49:476-484; doi:10.2337/diabetes.49.3.476

  4. Fried, G

    • Synaptotagmin III isoform is compartmentalized in pancreatic beta-cells and has a functional role in exocytosis. Diabetes March 2000 49:383-391; doi:10.2337/diabetes.49.3.383

  5. Frigato, F

    • Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate. Diabetes March 2000 49:476-484; doi:10.2337/diabetes.49.3.476

  6. Frittitta, L

    • A PC-1 amino acid variant (K121Q) is associated with faster progression of renal disease in patients with type 1 diabetes and albuminuria. Diabetes March 2000 49:521-524; doi:10.2337/diabetes.49.3.521

G

  1. Gade,

    • Insulin signaling and insulin sensitivity after exercise in human skeletal muscle. Diabetes March 2000 49:325-331; doi:10.2337/diabetes.49.3.325

  2. Garchon, H J

    • Genetic and physical mapping of a type 1 diabetes susceptibility gene (IDDM12) to a 100-kb phagemid artificial chromosome clone containing D2S72-CTLA4-D2S105 on chromosome 2q33. Diabetes March 2000 49:492-499; doi:10.2337/diabetes.49.3.492

  3. Giacca, A

    • Prolonged elevation of plasma free fatty acids impairs pancreatic beta-cell function in obese nondiabetic humans but not in individuals with type 2 diabetes. Diabetes March 2000 49:399-408; doi:10.2337/diabetes.49.3.399

  4. Goodyear, L J

    • Insulin signaling and insulin sensitivity after exercise in human skeletal muscle. Diabetes March 2000 49:325-331; doi:10.2337/diabetes.49.3.325

  5. Gutiérrez, C

    • Interleukin-6 gene polymorphism and insulin sensitivity. Diabetes March 2000 49:517-520; doi:10.2337/diabetes.49.3.517

H

  1. Hansen, B F

    • Insulin signaling and insulin sensitivity after exercise in human skeletal muscle. Diabetes March 2000 49:325-331; doi:10.2337/diabetes.49.3.325

  2. Hanson, R L

    • Type 2 diabetes and low birth weight: the role of paternal inheritance in the association of low birth weight and diabetes. Diabetes March 2000 49:445-449; doi:10.2337/diabetes.49.3.445

  3. Harris, T E

    • The extracellular calcium-sensing receptor on human beta-cells negatively modulates insulin secretion. Diabetes March 2000 49:409-417; doi:10.2337/diabetes.49.3.409

  4. Hawkes, C J

    • T-cell lines reactive to an immunodominant epitope of the tyrosine phosphatase-like autoantigen IA-2 in type 1 diabetes. Diabetes March 2000 49:356-366; doi:10.2337/diabetes.49.3.356

  5. Heaton, N

    • Renal glucose production compensates for the liver during the anhepatic phase of liver transplantation. Diabetes March 2000 49:450-456; doi:10.2337/diabetes.49.3.450

  6. Heine, R J

    • Increased levels of soluble vascular cell adhesion molecule 1 are associated with risk of cardiovascular mortality in type 2 diabetes: the Hoorn study. Diabetes March 2000 49:485-491; doi:10.2337/diabetes.49.3.485

  7. Heitmeier, M R

    • Anti-inflammatory actions of 15-deoxy-delta 12,14-prostaglandin J2 and troglitazone: evidence for heat shock-dependent and -independent inhibition of cytokine-induced inducible nitric oxide synthase expression. Diabetes March 2000 49:346-355; doi:10.2337/diabetes.49.3.346

  8. Henkel-Rieger, R

    • Isolation of INS-1-derived cell lines with robust ATP-sensitive K+ channel-dependent and -independent glucose-stimulated insulin secretion. Diabetes March 2000 49:424-430; doi:10.2337/diabetes.49.3.424

  9. Heudes, D

    • Early glomerular macrophage recruitment in streptozotocin-induced diabetic rats. Diabetes March 2000 49:466-475; doi:10.2337/diabetes.49.3.466

  10. Hirota, F

    • Brain-derived neurotrophic factor regulates glucose metabolism by modulating energy balance in diabetic mice. Diabetes March 2000 49:436-444; doi:10.2337/diabetes.49.3.436

  11. Hixson, J E

    • Linkage of serum insulin concentrations to chromosome 3p in Mexican Americans. Diabetes March 2000 49:513-516; doi:10.2337/diabetes.49.3.513

  12. Hohmeier, H E

    • Isolation of INS-1-derived cell lines with robust ATP-sensitive K+ channel-dependent and -independent glucose-stimulated insulin secretion. Diabetes March 2000 49:424-430; doi:10.2337/diabetes.49.3.424

  13. Hopkins, D I

    • Genetic and physical mapping of a type 1 diabetes susceptibility gene (IDDM12) to a 100-kb phagemid artificial chromosome clone containing D2S72-CTLA4-D2S105 on chromosome 2q33. Diabetes March 2000 49:492-499; doi:10.2337/diabetes.49.3.492

  14. Hosoda, K

    • Constitutively active mitogen-activated protein kinase kinase increases GLUT1 expression and recruits both GLUT1 and GLUT4 at the cell surface in 3T3-L1 adipocytes. Diabetes March 2000 49:332-339; doi:10.2337/diabetes.49.3.332

  15. Hsueh, W C

    • Linkage of serum insulin concentrations to chromosome 3p in Mexican Americans. Diabetes March 2000 49:513-516; doi:10.2337/diabetes.49.3.513

I

  1. Iismaa, T P

    • Quantitative and functional characterization of muscarinic receptor subtypes in insulin-secreting cell lines and rat pancreatic islets. Diabetes March 2000 49:392-398; doi:10.2337/diabetes.49.3.392

  2. Inoue, G

    • Constitutively active mitogen-activated protein kinase kinase increases GLUT1 expression and recruits both GLUT1 and GLUT4 at the cell surface in 3T3-L1 adipocytes. Diabetes March 2000 49:332-339; doi:10.2337/diabetes.49.3.332

  3. Inoue, T

    • Brain-derived neurotrophic factor regulates glucose metabolism by modulating energy balance in diabetic mice. Diabetes March 2000 49:436-444; doi:10.2337/diabetes.49.3.436

  4. Itakura, Y

    • Brain-derived neurotrophic factor regulates glucose metabolism by modulating energy balance in diabetic mice. Diabetes March 2000 49:436-444; doi:10.2337/diabetes.49.3.436

  5. Iwanaga, T

    • Diverse roles of K(ATP) channels learned from Kir6.2 genetically engineered mice. Diabetes March 2000 49:311-318; doi:10.2337/diabetes.49.3.311

J

  1. Jacob, C O

    • Genetic and physical mapping of a type 1 diabetes susceptibility gene (IDDM12) to a 100-kb phagemid artificial chromosome clone containing D2S72-CTLA4-D2S105 on chromosome 2q33. Diabetes March 2000 49:492-499; doi:10.2337/diabetes.49.3.492

  2. Jager, A

    • Increased levels of soluble vascular cell adhesion molecule 1 are associated with risk of cardiovascular mortality in type 2 diabetes: the Hoorn study. Diabetes March 2000 49:485-491; doi:10.2337/diabetes.49.3.485

  3. James, R F

    • Glucose modulation of insulin mRNA levels is dependent on transcription factor PDX-1 and occurs independently of changes in intracellular Ca2+. Diabetes March 2000 49:418-423; doi:10.2337/diabetes.49.3.418

  4. Jones, J S

    • Dysregulation of the insulin/IGF binding protein-1 axis in transgenic mice is associated with hyperinsulinemia and glucose intolerance. Diabetes March 2000 49:457-465; doi:10.2337/diabetes.49.3.457

  5. Jones, P M

    • The extracellular calcium-sensing receptor on human beta-cells negatively modulates insulin secretion. Diabetes March 2000 49:409-417; doi:10.2337/diabetes.49.3.409

  6. Joseph, S E

    • Renal glucose production compensates for the liver during the anhepatic phase of liver transplantation. Diabetes March 2000 49:450-456; doi:10.2337/diabetes.49.3.450

K

  1. Kerr, E A

    • Quantitative and functional characterization of muscarinic receptor subtypes in insulin-secreting cell lines and rat pancreatic islets. Diabetes March 2000 49:392-398; doi:10.2337/diabetes.49.3.392

  2. Kiens, B

    • Insulin signaling and insulin sensitivity after exercise in human skeletal muscle. Diabetes March 2000 49:325-331; doi:10.2337/diabetes.49.3.325

  3. Kim, B J

    • Zinc as a paracrine effector in pancreatic islet cell death. Diabetes March 2000 49:367-372; doi:10.2337/diabetes.49.3.367

  4. Kim, J W

    • Zinc as a paracrine effector in pancreatic islet cell death. Diabetes March 2000 49:367-372; doi:10.2337/diabetes.49.3.367

  5. Kim, K W

    • Zinc as a paracrine effector in pancreatic islet cell death. Diabetes March 2000 49:367-372; doi:10.2337/diabetes.49.3.367

  6. Kim, S

    • Zinc as a paracrine effector in pancreatic islet cell death. Diabetes March 2000 49:367-372; doi:10.2337/diabetes.49.3.367

  7. Kim, Y H

    • Zinc as a paracrine effector in pancreatic islet cell death. Diabetes March 2000 49:367-372; doi:10.2337/diabetes.49.3.367

  8. Knapp, M

    • Vitamin D receptor allele combinations influence genetic susceptibility to type 1 diabetes in Germans. Diabetes March 2000 49:504-507; doi:10.2337/diabetes.49.3.504

  9. Knowler, W C

    • Type 2 diabetes and low birth weight: the role of paternal inheritance in the association of low birth weight and diabetes. Diabetes March 2000 49:445-449; doi:10.2337/diabetes.49.3.445

  10. Koh, J Y

    • Zinc as a paracrine effector in pancreatic islet cell death. Diabetes March 2000 49:367-372; doi:10.2337/diabetes.49.3.367

  11. Koh, M

    • Constitutively active mitogen-activated protein kinase kinase increases GLUT1 expression and recruits both GLUT1 and GLUT4 at the cell surface in 3T3-L1 adipocytes. Diabetes March 2000 49:332-339; doi:10.2337/diabetes.49.3.332

  12. Kostense, P J

    • Increased levels of soluble vascular cell adhesion molecule 1 are associated with risk of cardiovascular mortality in type 2 diabetes: the Hoorn study. Diabetes March 2000 49:485-491; doi:10.2337/diabetes.49.3.485

L

  1. Larsson, O

    • Synaptotagmin III isoform is compartmentalized in pancreatic beta-cells and has a functional role in exocytosis. Diabetes March 2000 49:383-391; doi:10.2337/diabetes.49.3.383

  2. Lee, M K

    • Zinc as a paracrine effector in pancreatic islet cell death. Diabetes March 2000 49:367-372; doi:10.2337/diabetes.49.3.367

  3. Lee, M S

    • Zinc as a paracrine effector in pancreatic islet cell death. Diabetes March 2000 49:367-372; doi:10.2337/diabetes.49.3.367

  4. Lewis, G F

    • Prolonged elevation of plasma free fatty acids impairs pancreatic beta-cell function in obese nondiabetic humans but not in individuals with type 2 diabetes. Diabetes March 2000 49:399-408; doi:10.2337/diabetes.49.3.399

  5. Lindsay, R S

    • Type 2 diabetes and low birth weight: the role of paternal inheritance in the association of low birth weight and diabetes. Diabetes March 2000 49:445-449; doi:10.2337/diabetes.49.3.445

  6. Ling, Z

    • Interleukin-1beta-induced alteration in a beta-cell phenotype can reduce cellular sensitivity to conditions that cause necrosis but not to cytokine-induced apoptosis. Diabetes March 2000 49:340-345; doi:10.2337/diabetes.49.3.340

M

  1. MacCluer, J W

    • Linkage of serum insulin concentrations to chromosome 3p in Mexican Americans. Diabetes March 2000 49:513-516; doi:10.2337/diabetes.49.3.513

  2. Macfarlane, W M

    • Glucose modulation of insulin mRNA levels is dependent on transcription factor PDX-1 and occurs independently of changes in intracellular Ca2+. Diabetes March 2000 49:418-423; doi:10.2337/diabetes.49.3.418

  3. Macor, C

    • Induction of fatty acid translocase/CD36, peroxisome proliferator-activated receptor-gamma2, leptin, uncoupling proteins 2 and 3, and tumor necrosis factor-alpha gene expression in human subcutaneous fat by lipid infusion. Diabetes March 2000 49:319-324; doi:10.2337/diabetes.49.3.319

  4. Maggi, L B, Jr

    • Anti-inflammatory actions of 15-deoxy-delta 12,14-prostaglandin J2 and troglitazone: evidence for heat shock-dependent and -independent inhibition of cytokine-induced inducible nitric oxide synthase expression. Diabetes March 2000 49:346-355; doi:10.2337/diabetes.49.3.346

  5. Mandet, C

    • Early glomerular macrophage recruitment in streptozotocin-induced diabetic rats. Diabetes March 2000 49:466-475; doi:10.2337/diabetes.49.3.466

  6. Margaglione, M

    • A PC-1 amino acid variant (K121Q) is associated with faster progression of renal disease in patients with type 1 diabetes and albuminuria. Diabetes March 2000 49:521-524; doi:10.2337/diabetes.49.3.521

  7. Marks, J

    • T-cell lines reactive to an immunodominant epitope of the tyrosine phosphatase-like autoantigen IA-2 in type 1 diabetes. Diabetes March 2000 49:356-366; doi:10.2337/diabetes.49.3.356

  8. Markuns, J F

    • Insulin signaling and insulin sensitivity after exercise in human skeletal muscle. Diabetes March 2000 49:325-331; doi:10.2337/diabetes.49.3.325

  9. Marron, M P

    • Genetic and physical mapping of a type 1 diabetes susceptibility gene (IDDM12) to a 100-kb phagemid artificial chromosome clone containing D2S72-CTLA4-D2S105 on chromosome 2q33. Diabetes March 2000 49:492-499; doi:10.2337/diabetes.49.3.492

  10. Martinez Larrad, M T

    • Genetic and physical mapping of a type 1 diabetes susceptibility gene (IDDM12) to a 100-kb phagemid artificial chromosome clone containing D2S72-CTLA4-D2S105 on chromosome 2q33. Diabetes March 2000 49:492-499; doi:10.2337/diabetes.49.3.492

  11. Masuzaki, H

    • Constitutively active mitogen-activated protein kinase kinase increases GLUT1 expression and recruits both GLUT1 and GLUT4 at the cell surface in 3T3-L1 adipocytes. Diabetes March 2000 49:332-339; doi:10.2337/diabetes.49.3.332

  12. Matheny, M

    • Impaired leptin responsiveness in aged rats. Diabetes March 2000 49:431-435; doi:10.2337/diabetes.49.3.431

  13. Mayer, E K

    • T-cell lines reactive to an immunodominant epitope of the tyrosine phosphatase-like autoantigen IA-2 in type 1 diabetes. Diabetes March 2000 49:356-366; doi:10.2337/diabetes.49.3.356

  14. Meister, B

    • Synaptotagmin III isoform is compartmentalized in pancreatic beta-cells and has a functional role in exocytosis. Diabetes March 2000 49:383-391; doi:10.2337/diabetes.49.3.383

  15. Michel, O

    • Early glomerular macrophage recruitment in streptozotocin-induced diabetic rats. Diabetes March 2000 49:466-475; doi:10.2337/diabetes.49.3.466

  16. Miell, J P

    • Dysregulation of the insulin/IGF binding protein-1 axis in transgenic mice is associated with hyperinsulinemia and glucose intolerance. Diabetes March 2000 49:457-465; doi:10.2337/diabetes.49.3.457

  17. Miki, T

    • Diverse roles of K(ATP) channels learned from Kir6.2 genetically engineered mice. Diabetes March 2000 49:311-318; doi:10.2337/diabetes.49.3.311

  18. Miscio, G

    • A PC-1 amino acid variant (K121Q) is associated with faster progression of renal disease in patients with type 1 diabetes and albuminuria. Diabetes March 2000 49:521-524; doi:10.2337/diabetes.49.3.521

  19. Mitchell, B D

    • Linkage of serum insulin concentrations to chromosome 3p in Mexican Americans. Diabetes March 2000 49:513-516; doi:10.2337/diabetes.49.3.513

  20. Mittelman, S D

    • Prolonged elevation of plasma free fatty acids impairs pancreatic beta-cell function in obese nondiabetic humans but not in individuals with type 2 diabetes. Diabetes March 2000 49:399-408; doi:10.2337/diabetes.49.3.399

  21. Moore, R L

    • Impaired leptin responsiveness in aged rats. Diabetes March 2000 49:431-435; doi:10.2337/diabetes.49.3.431

  22. Mulder, H

    • Isolation of INS-1-derived cell lines with robust ATP-sensitive K+ channel-dependent and -independent glucose-stimulated insulin secretion. Diabetes March 2000 49:424-430; doi:10.2337/diabetes.49.3.424

  23. Muollo, B

    • Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate. Diabetes March 2000 49:476-484; doi:10.2337/diabetes.49.3.476

N

  1. Nagashima, K

    • Diverse roles of K(ATP) channels learned from Kir6.2 genetically engineered mice. Diabetes March 2000 49:311-318; doi:10.2337/diabetes.49.3.311

  2. Nakagawa, T

    • Brain-derived neurotrophic factor regulates glucose metabolism by modulating energy balance in diabetic mice. Diabetes March 2000 49:436-444; doi:10.2337/diabetes.49.3.436

  3. Nakao, K

    • Constitutively active mitogen-activated protein kinase kinase increases GLUT1 expression and recruits both GLUT1 and GLUT4 at the cell surface in 3T3-L1 adipocytes. Diabetes March 2000 49:332-339; doi:10.2337/diabetes.49.3.332

  4. Nakayama, C

    • Brain-derived neurotrophic factor regulates glucose metabolism by modulating energy balance in diabetic mice. Diabetes March 2000 49:436-444; doi:10.2337/diabetes.49.3.436

  5. Neugebauer, S

    • Association of the nitric oxide synthase gene polymorphism with an increased risk for progression to diabetic nephropathy in type 2 diabetes. Diabetes March 2000 49:500-503; doi:10.2337/diabetes.49.3.500

  6. Newgard, C B

    • Isolation of INS-1-derived cell lines with robust ATP-sensitive K+ channel-dependent and -independent glucose-stimulated insulin secretion. Diabetes March 2000 49:424-430; doi:10.2337/diabetes.49.3.424

  7. Nijpels, G

    • Increased levels of soluble vascular cell adhesion molecule 1 are associated with risk of cardiovascular mortality in type 2 diabetes: the Hoorn study. Diabetes March 2000 49:485-491; doi:10.2337/diabetes.49.3.485

  8. Nishimura, H

    • Constitutively active mitogen-activated protein kinase kinase increases GLUT1 expression and recruits both GLUT1 and GLUT4 at the cell surface in 3T3-L1 adipocytes. Diabetes March 2000 49:332-339; doi:10.2337/diabetes.49.3.332

  9. Nisoli, E

    • Induction of fatty acid translocase/CD36, peroxisome proliferator-activated receptor-gamma2, leptin, uncoupling proteins 2 and 3, and tumor necrosis factor-alpha gene expression in human subcutaneous fat by lipid infusion. Diabetes March 2000 49:319-324; doi:10.2337/diabetes.49.3.319

  10. Noguchi, H

    • Brain-derived neurotrophic factor regulates glucose metabolism by modulating energy balance in diabetic mice. Diabetes March 2000 49:436-444; doi:10.2337/diabetes.49.3.436

  11. Nonomura, T

    • Brain-derived neurotrophic factor regulates glucose metabolism by modulating energy balance in diabetic mice. Diabetes March 2000 49:436-444; doi:10.2337/diabetes.49.3.436

  12. Nosadini, R

    • Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate. Diabetes March 2000 49:476-484; doi:10.2337/diabetes.49.3.476

O

  1. Ogawa, Y

    • Constitutively active mitogen-activated protein kinase kinase increases GLUT1 expression and recruits both GLUT1 and GLUT4 at the cell surface in 3T3-L1 adipocytes. Diabetes March 2000 49:332-339; doi:10.2337/diabetes.49.3.332

  2. Oh, S H

    • Zinc as a paracrine effector in pancreatic islet cell death. Diabetes March 2000 49:367-372; doi:10.2337/diabetes.49.3.367

  3. Ono, M

    • Brain-derived neurotrophic factor regulates glucose metabolism by modulating energy balance in diabetic mice. Diabetes March 2000 49:436-444; doi:10.2337/diabetes.49.3.436

  4. Owerbach, D

    • Physical and genetic mapping of IDDM8 on chromosome 6q27. Diabetes March 2000 49:508-512; doi:10.2337/diabetes.49.3.508

P

  1. Pacini, G

    • Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate. Diabetes March 2000 49:476-484; doi:10.2337/diabetes.49.3.476

  2. Pani, M A

    • Vitamin D receptor allele combinations influence genetic susceptibility to type 1 diabetes in Germans. Diabetes March 2000 49:504-507; doi:10.2337/diabetes.49.3.504

  3. Park, Y

    • Genetic and physical mapping of a type 1 diabetes susceptibility gene (IDDM12) to a 100-kb phagemid artificial chromosome clone containing D2S72-CTLA4-D2S105 on chromosome 2q33. Diabetes March 2000 49:492-499; doi:10.2337/diabetes.49.3.492

  4. Perdereau, B

    • Early glomerular macrophage recruitment in streptozotocin-induced diabetic rats. Diabetes March 2000 49:466-475; doi:10.2337/diabetes.49.3.466

  5. Perin, P C

    • A PC-1 amino acid variant (K121Q) is associated with faster progression of renal disease in patients with type 1 diabetes and albuminuria. Diabetes March 2000 49:521-524; doi:10.2337/diabetes.49.3.521

  6. Pernet, A

    • Renal glucose production compensates for the liver during the anhepatic phase of liver transplantation. Diabetes March 2000 49:450-456; doi:10.2337/diabetes.49.3.450

  7. Persaud, S J

    • The extracellular calcium-sensing receptor on human beta-cells negatively modulates insulin secretion. Diabetes March 2000 49:409-417; doi:10.2337/diabetes.49.3.409

  8. Piarulli, F

    • Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate. Diabetes March 2000 49:476-484; doi:10.2337/diabetes.49.3.476

  9. Pipeleers, D G

    • Interleukin-1beta-induced alteration in a beta-cell phenotype can reduce cellular sensitivity to conditions that cause necrosis but not to cytokine-induced apoptosis. Diabetes March 2000 49:340-345; doi:10.2337/diabetes.49.3.340

  10. Piras, G P

    • A PC-1 amino acid variant (K121Q) is associated with faster progression of renal disease in patients with type 1 diabetes and albuminuria. Diabetes March 2000 49:521-524; doi:10.2337/diabetes.49.3.521

  11. Pizzuti, A

    • A PC-1 amino acid variant (K121Q) is associated with faster progression of renal disease in patients with type 1 diabetes and albuminuria. Diabetes March 2000 49:521-524; doi:10.2337/diabetes.49.3.521

  12. Potter, D

    • Renal glucose production compensates for the liver during the anhepatic phase of liver transplantation. Diabetes March 2000 49:450-456; doi:10.2337/diabetes.49.3.450

  13. Prentki, M

    • Isolation of INS-1-derived cell lines with robust ATP-sensitive K+ channel-dependent and -independent glucose-stimulated insulin secretion. Diabetes March 2000 49:424-430; doi:10.2337/diabetes.49.3.424

  14. Pugeat, M

    • Interleukin-6 gene polymorphism and insulin sensitivity. Diabetes March 2000 49:517-520; doi:10.2337/diabetes.49.3.517

R

  1. Raffel, L J

    • Genetic and physical mapping of a type 1 diabetes susceptibility gene (IDDM12) to a 100-kb phagemid artificial chromosome clone containing D2S72-CTLA4-D2S105 on chromosome 2q33. Diabetes March 2000 49:492-499; doi:10.2337/diabetes.49.3.492

  2. Rhodes, C J

    • Synaptotagmin III isoform is compartmentalized in pancreatic beta-cells and has a functional role in exocytosis. Diabetes March 2000 49:383-391; doi:10.2337/diabetes.49.3.383

  3. Ricart, W

    • Interleukin-6 gene polymorphism and insulin sensitivity. Diabetes March 2000 49:517-520; doi:10.2337/diabetes.49.3.517

  4. Richart, C

    • Interleukin-6 gene polymorphism and insulin sensitivity. Diabetes March 2000 49:517-520; doi:10.2337/diabetes.49.3.517

  5. Richter, E A

    • Insulin signaling and insulin sensitivity after exercise in human skeletal muscle. Diabetes March 2000 49:325-331; doi:10.2337/diabetes.49.3.325

  6. Roep, B O

    • T-cell lines reactive to an immunodominant epitope of the tyrosine phosphatase-like autoantigen IA-2 in type 1 diabetes. Diabetes March 2000 49:356-366; doi:10.2337/diabetes.49.3.356

  7. Rotter, J I

    • Genetic and physical mapping of a type 1 diabetes susceptibility gene (IDDM12) to a 100-kb phagemid artificial chromosome clone containing D2S72-CTLA4-D2S105 on chromosome 2q33. Diabetes March 2000 49:492-499; doi:10.2337/diabetes.49.3.492

  8. Roumain, J

    • Type 2 diabetes and low birth weight: the role of paternal inheritance in the association of low birth weight and diabetes. Diabetes March 2000 49:445-449; doi:10.2337/diabetes.49.3.445

S

  1. Sadeghi, H

    • Anti-inflammatory actions of 15-deoxy-delta 12,14-prostaglandin J2 and troglitazone: evidence for heat shock-dependent and -independent inhibition of cytokine-induced inducible nitric oxide synthase expression. Diabetes March 2000 49:346-355; doi:10.2337/diabetes.49.3.346

  2. Saller, A

    • Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate. Diabetes March 2000 49:476-484; doi:10.2337/diabetes.49.3.476

  3. Sambataro, M

    • Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate. Diabetes March 2000 49:476-484; doi:10.2337/diabetes.49.3.476

  4. Sassy-Prigent, C

    • Early glomerular macrophage recruitment in streptozotocin-induced diabetic rats. Diabetes March 2000 49:466-475; doi:10.2337/diabetes.49.3.466

  5. Scarim, A L

    • Anti-inflammatory actions of 15-deoxy-delta 12,14-prostaglandin J2 and troglitazone: evidence for heat shock-dependent and -independent inhibition of cytokine-induced inducible nitric oxide synthase expression. Diabetes March 2000 49:346-355; doi:10.2337/diabetes.49.3.346

  6. Scarpace, P J

    • Impaired leptin responsiveness in aged rats. Diabetes March 2000 49:431-435; doi:10.2337/diabetes.49.3.431

  7. Schloot, N C

    • T-cell lines reactive to an immunodominant epitope of the tyrosine phosphatase-like autoantigen IA-2 in type 1 diabetes. Diabetes March 2000 49:356-366; doi:10.2337/diabetes.49.3.356

  8. Seino, S

    • Diverse roles of K(ATP) channels learned from Kir6.2 genetically engineered mice. Diabetes March 2000 49:311-318; doi:10.2337/diabetes.49.3.311
    • Synaptotagmin III isoform is compartmentalized in pancreatic beta-cells and has a functional role in exocytosis. Diabetes March 2000 49:383-391; doi:10.2337/diabetes.49.3.383

  9. Serrano-Rios, M

    • Genetic and physical mapping of a type 1 diabetes susceptibility gene (IDDM12) to a 100-kb phagemid artificial chromosome clone containing D2S72-CTLA4-D2S105 on chromosome 2q33. Diabetes March 2000 49:492-499; doi:10.2337/diabetes.49.3.492

  10. Sfriso, A

    • Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate. Diabetes March 2000 49:476-484; doi:10.2337/diabetes.49.3.476

  11. She, J X

    • Genetic and physical mapping of a type 1 diabetes susceptibility gene (IDDM12) to a 100-kb phagemid artificial chromosome clone containing D2S72-CTLA4-D2S105 on chromosome 2q33. Diabetes March 2000 49:492-499; doi:10.2337/diabetes.49.3.492

  12. Shepherd, R M

    • Glucose modulation of insulin mRNA levels is dependent on transcription factor PDX-1 and occurs independently of changes in intracellular Ca2+. Diabetes March 2000 49:418-423; doi:10.2337/diabetes.49.3.418

  13. Sims, N

    • Quantitative and functional characterization of muscarinic receptor subtypes in insulin-secreting cell lines and rat pancreatic islets. Diabetes March 2000 49:392-398; doi:10.2337/diabetes.49.3.392

  14. Squires, P E

    • The extracellular calcium-sensing receptor on human beta-cells negatively modulates insulin secretion. Diabetes March 2000 49:409-417; doi:10.2337/diabetes.49.3.409

  15. Stehouwer, C D

    • Increased levels of soluble vascular cell adhesion molecule 1 are associated with risk of cardiovascular mortality in type 2 diabetes: the Hoorn study. Diabetes March 2000 49:485-491; doi:10.2337/diabetes.49.3.485

  16. Suga, J

    • Constitutively active mitogen-activated protein kinase kinase increases GLUT1 expression and recruits both GLUT1 and GLUT4 at the cell surface in 3T3-L1 adipocytes. Diabetes March 2000 49:332-339; doi:10.2337/diabetes.49.3.332

T

  1. Taiji, M

    • Brain-derived neurotrophic factor regulates glucose metabolism by modulating energy balance in diabetic mice. Diabetes March 2000 49:436-444; doi:10.2337/diabetes.49.3.436

  2. Tassi, V

    • A PC-1 amino acid variant (K121Q) is associated with faster progression of renal disease in patients with type 1 diabetes and albuminuria. Diabetes March 2000 49:521-524; doi:10.2337/diabetes.49.3.521

  3. Thomas, S

    • A PC-1 amino acid variant (K121Q) is associated with faster progression of renal disease in patients with type 1 diabetes and albuminuria. Diabetes March 2000 49:521-524; doi:10.2337/diabetes.49.3.521

  4. Tonello, C

    • Induction of fatty acid translocase/CD36, peroxisome proliferator-activated receptor-gamma2, leptin, uncoupling proteins 2 and 3, and tumor necrosis factor-alpha gene expression in human subcutaneous fat by lipid infusion. Diabetes March 2000 49:319-324; doi:10.2337/diabetes.49.3.319

  5. Trevisan, R

    • A PC-1 amino acid variant (K121Q) is associated with faster progression of renal disease in patients with type 1 diabetes and albuminuria. Diabetes March 2000 49:521-524; doi:10.2337/diabetes.49.3.521

  6. Trischitta, V

    • A PC-1 amino acid variant (K121Q) is associated with faster progression of renal disease in patients with type 1 diabetes and albuminuria. Diabetes March 2000 49:521-524; doi:10.2337/diabetes.49.3.521

  7. Tsuchida, A

    • Brain-derived neurotrophic factor regulates glucose metabolism by modulating energy balance in diabetic mice. Diabetes March 2000 49:436-444; doi:10.2337/diabetes.49.3.436

  8. Tümer, N

    • Impaired leptin responsiveness in aged rats. Diabetes March 2000 49:431-435; doi:10.2337/diabetes.49.3.431

U

  1. Umpleby, M A

    • Renal glucose production compensates for the liver during the anhepatic phase of liver transplantation. Diabetes March 2000 49:450-456; doi:10.2337/diabetes.49.3.450

  2. Usadel, K H

    • Vitamin D receptor allele combinations influence genetic susceptibility to type 1 diabetes in Germans. Diabetes March 2000 49:504-507; doi:10.2337/diabetes.49.3.504

V

  1. Van de Casteele, M

    • Interleukin-1beta-induced alteration in a beta-cell phenotype can reduce cellular sensitivity to conditions that cause necrosis but not to cytokine-induced apoptosis. Diabetes March 2000 49:340-345; doi:10.2337/diabetes.49.3.340

  2. van Hinsbergh, V W

    • Increased levels of soluble vascular cell adhesion molecule 1 are associated with risk of cardiovascular mortality in type 2 diabetes: the Hoorn study. Diabetes March 2000 49:485-491; doi:10.2337/diabetes.49.3.485

  3. Velussi, M

    • Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate. Diabetes March 2000 49:476-484; doi:10.2337/diabetes.49.3.476

  4. Vendrell, J

    • Interleukin-6 gene polymorphism and insulin sensitivity. Diabetes March 2000 49:517-520; doi:10.2337/diabetes.49.3.517

  5. Vettor, R

    • Induction of fatty acid translocase/CD36, peroxisome proliferator-activated receptor-gamma2, leptin, uncoupling proteins 2 and 3, and tumor necrosis factor-alpha gene expression in human subcutaneous fat by lipid infusion. Diabetes March 2000 49:319-324; doi:10.2337/diabetes.49.3.319

  6. Viberti, G C

    • A PC-1 amino acid variant (K121Q) is associated with faster progression of renal disease in patients with type 1 diabetes and albuminuria. Diabetes March 2000 49:521-524; doi:10.2337/diabetes.49.3.521

W

  1. Watanabe, R M

    • Accurate measurement of endogenous insulin secretion does not require separate assessment of C-peptide kinetics. Diabetes March 2000 49:373-382; doi:10.2337/diabetes.49.3.373

  2. Watanabe, T

    • Association of the nitric oxide synthase gene polymorphism with an increased risk for progression to diabetic nephropathy in type 2 diabetes. Diabetes March 2000 49:500-503; doi:10.2337/diabetes.49.3.500

  3. Watanabe, Y

    • Constitutively active mitogen-activated protein kinase kinase increases GLUT1 expression and recruits both GLUT1 and GLUT4 at the cell surface in 3T3-L1 adipocytes. Diabetes March 2000 49:332-339; doi:10.2337/diabetes.49.3.332

  4. Weigand, C

    • Anti-inflammatory actions of 15-deoxy-delta 12,14-prostaglandin J2 and troglitazone: evidence for heat shock-dependent and -independent inhibition of cytokine-induced inducible nitric oxide synthase expression. Diabetes March 2000 49:346-355; doi:10.2337/diabetes.49.3.346

  5. Willemen, S J

    • T-cell lines reactive to an immunodominant epitope of the tyrosine phosphatase-like autoantigen IA-2 in type 1 diabetes. Diabetes March 2000 49:356-366; doi:10.2337/diabetes.49.3.356

  6. Wilson, J R

    • Quantitative and functional characterization of muscarinic receptor subtypes in insulin-secreting cell lines and rat pancreatic islets. Diabetes March 2000 49:392-398; doi:10.2337/diabetes.49.3.392

  7. Wojtaszewski, J F

    • Insulin signaling and insulin sensitivity after exercise in human skeletal muscle. Diabetes March 2000 49:325-331; doi:10.2337/diabetes.49.3.325

Y

  1. Yamamoto, Y

    • Constitutively active mitogen-activated protein kinase kinase increases GLUT1 expression and recruits both GLUT1 and GLUT4 at the cell surface in 3T3-L1 adipocytes. Diabetes March 2000 49:332-339; doi:10.2337/diabetes.49.3.332

  2. Yang, J J

    • Genetic and physical mapping of a type 1 diabetes susceptibility gene (IDDM12) to a 100-kb phagemid artificial chromosome clone containing D2S72-CTLA4-D2S105 on chromosome 2q33. Diabetes March 2000 49:492-499; doi:10.2337/diabetes.49.3.492

  3. Yang, M C

    • Genetic and physical mapping of a type 1 diabetes susceptibility gene (IDDM12) to a 100-kb phagemid artificial chromosome clone containing D2S72-CTLA4-D2S105 on chromosome 2q33. Diabetes March 2000 49:492-499; doi:10.2337/diabetes.49.3.492

  4. Yang, S N

    • Synaptotagmin III isoform is compartmentalized in pancreatic beta-cells and has a functional role in exocytosis. Diabetes March 2000 49:383-391; doi:10.2337/diabetes.49.3.383

  5. Yoshimasa, Y

    • Constitutively active mitogen-activated protein kinase kinase increases GLUT1 expression and recruits both GLUT1 and GLUT4 at the cell surface in 3T3-L1 adipocytes. Diabetes March 2000 49:332-339; doi:10.2337/diabetes.49.3.332

Z

  1. Zeidler, A

    • Genetic and physical mapping of a type 1 diabetes susceptibility gene (IDDM12) to a 100-kb phagemid artificial chromosome clone containing D2S72-CTLA4-D2S105 on chromosome 2q33. Diabetes March 2000 49:492-499; doi:10.2337/diabetes.49.3.492

  2. Zucaro, L

    • A PC-1 amino acid variant (K121Q) is associated with faster progression of renal disease in patients with type 1 diabetes and albuminuria. Diabetes March 2000 49:521-524; doi:10.2337/diabetes.49.3.521

Current Issue

  1. February 2012, 61 (2)
  1. Current Issue
  1. Alert me to new issues of Diabetes
Advertisement